Home › Stocks › NAMS

NAMS — NEWAMSTERDAM PHARMA COMPANY

Reported value held$4.74B
Funds holding (latest)326
SectorHealth Care

What is a 13F filing? Who files one and when · What 13F filings can't tell you

Funds holding (Q2 2026)210
Institutional value$4.75B · 141.29M sh
New / Add / Cut / Exit51 / 73 / 53 / 23 · Updated 2026-11-14
Top-5 / Top-10 concentration44.6% / 62.4%
Institutional holdings change Reducing -7.5% (-10.62M sh)
Institutional value change Down -2.2%

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

As of Q2 2026, 210 SEC-registered investment managers reported holding NAMS (NEWAMSTERDAM PHARMA COMPANY) in their latest 13F filings, with a combined reported value of $4.75B across 141.29M shares. That is -7.5% by share count (-10.62M shares) versus the previous quarter, while reported value moved -2.2%. Ownership is concentrated: the five largest holders account for 44.6% of reported value and the top ten for 62.4%.

Compared with the prior quarter, 51 opened new positions, 73 added to existing stakes, 53 trimmed, 23 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.

Major shareholders of NEWAMSTERDAM PHARMA COMPANY (NAMS) include Frazier Life Sciences Management, L.P., Capital World Investors, RA CAPITAL MANAGEMENT, L.P., ranked by reported 13F value among the 326 institutional holders on this page.

NAMS is classified in the Health Care sector.

All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.

Legendary Investors Holding NAMS

The superinvestors we track who report NAMS in their latest 13F filing — each shown at that manager’s own most recent quarter.

Investor Quarter Shares Value Portfolio Weight Change
Viking Global Investors Q2 2026 4.20M $142.46M 0.41% Hold
Lee Ainslie Q2 2026 3.27M $110.75M 1.00% Add

Which stocks do these investors own together? →  ·  Embed this widget →

Institutional Ownership by Quarter

Quarter Funds holding Shares Value QoQ Net Change
Q3 2026 119 44.21M $1.07B +8.9%
Q2 2026 210 141.29M $4.75B -7.5%
Q1 2026 181 145.89M $4.67B +2.9%
Q4 2025 195 139.30M $4.88B -4.9%
Q3 2025 143 142.67M $4.05B +4.3%
Q2 2025 136 136.29M $2.47B +7.9%
Q1 2025 129 125.35M $2.57B +16.9%
Q4 2024 134 108.44M $2.79B +20.6%

Over the 8 quarters shown, institutional share counts decreased 59% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q4 2024 (+20.6%).

Top Institutional Holders (Q3 2026) — 25 funds

FundSharesValuePortfolio WeightChange
Capital World Investors 12.88M $313.28M 0.04% Add
Fidelity Management & Research (FMR) 12.12M $294.68M 0.01% Add
Medicxi Ventures Management (Jersey) Ltd history 2.18M $53.07M 41.90% Reduce
Capital International Investors 1.84M $44.80M 0.01% Add
JPMorgan Chase & Co 1.23M $29.28M 0.00% Add
Aberdeen Group plc 1.18M $28.80M 0.04% Add
BlackRock Inc 1.04M $25.31M 0.00% Reduce
BNP Paribas Asset Management Holding S.A. 874.57K $21.27M 0.02% Add
AMERICAN CENTURY COMPANIES INC 865.40K $21.05M 0.01% Add
Morgan Stanley 836.58K $20.35M 0.00% Add
Franklin Resources 866.53K $18.14M 0.00% Reduce
NWI MANAGEMENT LP history 702.00K $17.07M 0.76% Hold
TimesSquare Capital Management, LLC 573.19K $13.94M 0.23% Reduce
KENNEDY CAPITAL MANAGEMENT LLC 547.63K $13.32M 0.25% Add
Qube Research & Technologies Ltd 373.27K $9.08M 0.02% Add
Jump Financial, LLC 357.52K $8.69M 0.08% Add
BNY Mellon 337.98K $8.22M 0.00% Reduce
Mizuho Markets Cayman LP history 309.16K $7.52M 0.52% Add
VICTORY CAPITAL MANAGEMENT INC 308.83K $7.51M 0.00% Add
Atle Fund Management AB history 303.82K $7.39M 1.98% Add
BARCLAYS PLC 280.41K $6.82M 0.01% Add
Affinity Asset Advisors, LLC 275.00K $6.69M 0.31% Hold
HRT FINANCIAL LP 225.08K $5.47M 0.02% Reduce
Deutsche Bank AG 204.46K $4.97M 0.00% Add
VANGUARD PORTFOLIO MANAGEMENT LLC 196.63K $4.78M 0.00% Add

↑ Back to the top of the holders list

Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders

Q2 2026 — 25 funds

FundSharesValuePortfolio WeightChange
Frazier Life Sciences Management, L.P. history 18.09M $613.03M 13.35% Add
Capital World Investors 12.23M $414.49M 0.05% Add
Capital World Investors 12.23M $414.49M 0.05% Add
Fidelity Management & Research (FMR) 10.34M $350.41M 0.02% Add
RA CAPITAL MANAGEMENT, L.P. history 9.55M $323.66M 2.81% Hold
FCPM III SERVICES B.V. history 8.49M $287.74M 38.34% Reduce
DEERFIELD MANAGEMENT COMPANY, L.P. history 4.26M $144.53M 1.81% Hold
Viking Global Investors 4.20M $142.46M 0.41% Hold
VIKING GLOBAL INVESTORS LP 4.20M $142.46M 0.41% Hold
Bain Capital Life Sciences Investors, LLC history 3.81M $129.00M 7.67% Reduce
Maverick Capital history 3.27M $110.75M 1.00% Add
MAVERICK CAPITAL LTD history 3.27M $110.75M 1.03% Add
Duquesne Family Office LLC history 3.07M $104.05M 2.31% Hold
Jupiter Topco LLC 2.54M $86.01M 0.04% New
Medicxi Ventures Management (Jersey) Ltd history 2.21M $74.85M 42.19% Reduce
JENNISON ASSOCIATES LLC 2.10M $71.25M 0.04% Reduce
Orbis Allan Gray Ltd 1.75M $59.23M 0.20% New
Polar Capital Holdings Plc 1.72M $58.44M 0.17% Reduce
Capital International Investors 1.72M $58.41M 0.01% Add
WESTFIELD CAPITAL MANAGEMENT CO LP 1.54M $52.07M 0.17% Reduce
Castle Hook Partners LP history 1.37M $46.46M 0.21% Add
AMERIPRISE FINANCIAL INC 1.25M $42.48M 0.01% Add
ALLIANCEBERNSTEIN L.P. 1.26M $40.33M 0.01% Add
PRICE T ROWE ASSOCIATES INC /MD/ 1.17M $39.56M 0.00% New
JPMorgan Chase & Co 1.13M $38.37M 0.00% Add

Q1 2026 — 25 funds

FundSharesValuePortfolio WeightChange
Frazier Life Sciences Management, L.P. history 16.94M $542.37M 13.96% Hold
Capital World Investors 11.11M $355.60M 0.05% Add
Capital World Investors 11.11M $355.60M 0.05% Add
RA CAPITAL MANAGEMENT, L.P. history 9.55M $305.70M 3.24% Hold
FCPM III SERVICES B.V. history 9.20M $294.46M 40.77% Hold
Fidelity Management & Research (FMR) 8.77M $280.59M 0.02% Add
Bain Capital Life Sciences Investors, LLC history 7.31M $233.88M 21.09% Hold
Wellington Management Group 5.12M $163.76M 0.03% Add
WELLINGTON MANAGEMENT GROUP LLP 5.12M $163.76M 0.03% Add
DEERFIELD MANAGEMENT COMPANY, L.P. history 4.26M $136.52M 1.80% Add
Viking Global Investors 4.20M $134.56M 0.38% Hold
VIKING GLOBAL INVESTORS LP 4.20M $134.56M 0.38% Hold
Duquesne Family Office LLC history 3.07M $98.28M 3.10% Hold
Polar Capital Holdings Plc 2.83M $90.64M 0.40% Add
JENNISON ASSOCIATES LLC 2.75M $88.04M 0.06% Reduce
Medicxi Ventures Management (Jersey) Ltd history 2.67M $85.60M 8.72% Reduce
Janus Henderson Group 2.26M $72.25M 0.04% Reduce
WESTFIELD CAPITAL MANAGEMENT CO LP 2.20M $70.52M 0.30% New
Maverick Capital history 2.19M $69.99M 0.81% Add
MAVERICK CAPITAL LTD history 2.19M $69.99M 0.84% Add
Goldman Sachs Group 1.95M $62.30M 0.02% Add
Capital International Investors 1.44M $46.13M 0.01% Reduce
ALLIANCEBERNSTEIN L.P. 1.20M $42.07M 0.01% Reduce
ADAGE CAPITAL PARTNERS GP, L.L.C. 1.11M $35.42M 0.06% Reduce
Castle Hook Partners LP history 1.04M $33.37M 0.14% Reduce

Q4 2025 — 25 funds

FundSharesValuePortfolio WeightChange
Frazier Life Sciences Management, L.P. history 16.94M $594.39M 15.96% Add
Capital World Investors 9.98M $350.24M 0.05% Add
Capital World Investors 9.98M $350.24M 0.05% Add
RA CAPITAL MANAGEMENT, L.P. history 9.55M $335.02M 3.43% Reduce
FCPM III SERVICES B.V. history 9.20M $322.70M 42.30% Hold
Bain Capital Life Sciences Investors, LLC history 7.31M $256.31M 19.63% Reduce
Fidelity Management & Research (FMR) 6.41M $224.97M 0.01% Add
Wellington Management Group 5.03M $176.56M 0.03% Add
WELLINGTON MANAGEMENT GROUP LLP 5.03M $176.56M 0.04% Add
Viking Global Investors 4.20M $147.46M 0.39% Reduce
VIKING GLOBAL INVESTORS LP 4.20M $147.46M 0.39% Reduce
DEERFIELD MANAGEMENT COMPANY, L.P. history 4.16M $146.10M 2.06% Reduce
JENNISON ASSOCIATES LLC 3.49M $122.40M 0.07% Reduce
Duquesne Family Office LLC history 3.07M $107.70M 2.57% Add
Medicxi Ventures Management (Jersey) Ltd history 2.87M $100.66M 12.06% Hold
Polar Capital Holdings Plc 2.78M $97.39M 0.45% Reduce
Janus Henderson Group 2.34M $82.30M 0.04% Add
Capital International Investors 2.06M $72.35M 0.01% Hold
Maverick Capital history 1.89M $66.45M 0.71% Add
MAVERICK CAPITAL LTD history 1.89M $66.45M 0.73% Add
Goldman Sachs Group 1.73M $60.54M 0.03% Add
ADAGE CAPITAL PARTNERS GP, L.L.C. 1.41M $49.34M 0.07% Reduce
ALLIANCEBERNSTEIN L.P. 1.30M $45.63M 0.01% Reduce
Castle Hook Partners LP history 1.09M $38.06M 0.16% New
Cormorant Asset Management, LP history 1.00M $35.08M 1.62% Reduce

Q3 2025 — 25 funds

FundSharesValuePortfolio WeightChange
Frazier Life Sciences Management, L.P. history 16.70M $475.00M 14.23% Add
Bain Capital Life Sciences Investors, LLC history 10.72M $304.85M 20.23% Hold
RA CAPITAL MANAGEMENT, L.P. history 10.14M $288.35M 3.55% Hold
Capital World Investors 9.82M $279.36M 0.04% Add
Capital World Investors 9.82M $279.36M 0.04% Add
FCPM III SERVICES B.V. history 9.21M $262.00M 52.36% Reduce
VIKING GLOBAL INVESTORS LP 6.48M $184.16M 0.48% Reduce
Viking Global Investors 6.48M $184.16M 0.48% Reduce
Fidelity Management & Research (FMR) 5.54M $157.42M 0.01% Add
DEERFIELD MANAGEMENT COMPANY, L.P. history 4.27M $121.34M 1.95% Reduce
JENNISON ASSOCIATES LLC 4.20M $119.41M 0.07% Add
WELLINGTON MANAGEMENT GROUP LLP 4.02M $114.33M 0.02% Add
Wellington Management Group 4.02M $114.33M 0.02% Add
Polar Capital Holdings Plc 2.91M $82.81M 0.43% Add
Medicxi Ventures Management (Jersey) Ltd history 2.87M $81.61M 10.96% Hold
ADAGE CAPITAL PARTNERS GP, L.L.C. 2.58M $73.28M 0.12% Reduce
Cormorant Asset Management, LP history 2.17M $61.86M 4.27% Hold
ALLIANCEBERNSTEIN L.P. 2.14M $60.91M 0.02% Reduce
Janus Henderson Group 2.12M $60.15M 0.03% Add
Capital International Investors 2.06M $58.66M 0.01% Hold
Duquesne Family Office LLC history 1.92M $54.71M 1.54% Add
MAVERICK CAPITAL LTD history 1.50M $42.80M 0.59% Reduce
Maverick Capital history 1.50M $42.80M 0.57% Reduce
Morgan Stanley 1.50M $42.59M 0.00% Add
JPMorgan Chase & Co 1.30M $37.04M 0.01% Reduce

Q2 2025 — 25 funds

FundSharesValuePortfolio WeightChange
Frazier Life Sciences Management, L.P. history 16.61M $300.75M 12.03% Add
Bain Capital Life Sciences Investors, LLC history 10.72M $194.12M 24.29% Hold
FCPM III SERVICES B.V. history 10.63M $192.55M 52.16% Reduce
RA CAPITAL MANAGEMENT, L.P. history 10.14M $183.62M 3.09% Hold
Capital World Investors 8.39M $151.90M 0.02% Add
Capital World Investors 8.39M $151.90M 0.02% Add
VIKING GLOBAL INVESTORS LP 6.98M $126.38M 0.36% Hold
Viking Global Investors 6.98M $126.38M 0.36% Hold
DEERFIELD MANAGEMENT COMPANY, L.P. history 5.12M $92.65M 1.81% Add
WELLINGTON MANAGEMENT GROUP LLP 3.32M $60.18M 0.01% Reduce
Wellington Management Group 3.32M $60.18M 0.01% Reduce
ADAGE CAPITAL PARTNERS GP, L.L.C. 3.01M $54.57M 0.09% Add
JENNISON ASSOCIATES LLC 2.95M $53.35M 0.03% Reduce
Medicxi Ventures Management (Jersey) Ltd history 2.87M $51.97M 12.16% Hold
Polar Capital Holdings Plc 2.52M $45.60M 0.24% Add
ALLIANCEBERNSTEIN L.P. 2.33M $42.22M 0.01% Add
Cormorant Asset Management, LP history 2.17M $39.39M 2.93% Add
Capital International Investors 2.06M $37.35M 0.01% Hold
Janus Henderson Group 1.96M $35.59M 0.02% Reduce
Fidelity Management & Research (FMR) 1.90M $34.49M 0.00% Add
Woodline Partners LP 1.90M $34.36M 0.18% Reduce
Pictet Asset Management Holding SA 1.82M $32.90M 0.03% Hold
MAVERICK CAPITAL LTD history 1.53M $27.74M 0.42% Add
Maverick Capital history 1.53M $27.74M 0.42% Add
JPMorgan Chase & Co 1.46M $26.42M 0.00% Add

View all 326 fund holders →

New Positions (Q2 2026)

Fully Exited (vs previous quarter)

Fund Position History — shares by quarter (top 20 funds)

FundQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022
Capital World Investors 12.88M 12.23M 11.11M 9.98M 9.82M 8.39M 6.80M 1.02M — — — — — — — —
Fidelity Management & Research (FMR) 12.12M 10.34M 8.77M 6.41M 5.54M 1.90M 963.82K 212 330.41K 243.70K 243.70K — — — — —
Medicxi Ventures Management (Jersey) Ltd 2.18M 2.21M 2.67M 2.87M 2.87M 2.87M 2.87M 2.87M 2.87M 2.87M 2.87M 2.87M 2.87M — — —
Capital International Investors 1.84M 1.72M 1.44M 2.06M 2.06M 2.06M 2.06M 2.06M — — — — — — — —
JPMorgan Chase & Co 1.23M 1.13M 884.23K 999.98K 1.30M 1.46M 991.32K 60.98K 22.35K 8.07K 4.32K — 2.62K 11.46K 22.37K 1.10K
Aberdeen Group plc 1.18M 1.10M 837.00K 729.48K 661.95K 735.03K 376.86K 179.06K 129.06K 76.00K — — — — — —
BlackRock Inc 1.04M 1.06M 886.62K 849.78K 622.51K 571.67K 497.98K 441.52K 66.67K — — — — — — —
BNP Paribas Asset Management Holding S.A. 874.57K 781.14K 957.44K 177.02K — — — — — — — — — — — —
AMERICAN CENTURY COMPANIES INC 865.40K 684.81K 519.46K 603.40K 624.28K 532.92K 528.83K 346.57K — — — — — — — —
Morgan Stanley 836.58K 575.83K 555.76K 532.80K 1.50M 637.71K 437.54K 430.10K 203.21K 24.69K 177.59K 28.54K 1.70K 808 503 —
Franklin Resources 866.53K 993.92K 770.16K 769.12K 405.82K 334.21K 255.91K — — — — — — — — —
NWI MANAGEMENT LP 702.00K 702.00K 702.00K 702.00K — — — — — — — — — — — —
TimesSquare Capital Management, LLC 573.19K 796.16K 751.99K 822.30K 837.37K 872.54K 891.09K 895.57K 255.25K 246.09K 228.62K — — — — —
KENNEDY CAPITAL MANAGEMENT LLC 547.63K 421.37K 408.49K 172.93K 146.72K 13.68K — 7.95K 14.05K 11.85K — — — — — —
Qube Research & Technologies Ltd 373.27K 47.09K — — — — — — — — — — — — — —
Jump Financial, LLC 357.52K 144.51K — — — — — 25.40K — — — — — — — —
BNY Mellon 337.98K 353.30K 378.80K 391.83K 333.00K 352.95K — — — — — — — — — —
Mizuho Markets Cayman LP 309.16K 150.54K 52.23K 47.88K — — — — — — — — — — — —
VICTORY CAPITAL MANAGEMENT INC 308.83K 172.66K 172.66K — — — — — — — — — — — — —
Atle Fund Management AB 303.82K 248.85K 94.80K 197.04K 193.62K 157.22K 107.78K 138.98K 138.98K 75.79K 22.39K — — — — —

Download holders (CSV)

FAQ

Which funds hold NAMS?

As of 2026-Q2, 210 institutional funds reported holding NAMS (NEWAMSTERDAM PHARMA COMPANY) in SEC 13F filings, with a combined reported value of $4.75B.

How many shares of NAMS do institutions own?

13F filers reported 141.29M shares of NAMS, worth $4.75B in aggregate at the end of 2026-Q2.

Is institutional ownership of NAMS rising or falling?

Share counts moved -7.5% versus the prior quarter — distribution.

Who are the top institutional holders of NAMS?

The largest 13F holders are Frazier Life Sciences Management, L.P., Capital World Investors, RA CAPITAL MANAGEMENT, L.P., Capital World Investors, Fidelity Management & Research (FMR); the top 25 are ranked at the top of this page.

Who are the major shareholders of NEWAMSTERDAM PHARMA COMPANY?

The major shareholders of NEWAMSTERDAM PHARMA COMPANY (NAMS) by reported 13F value are Frazier Life Sciences Management, L.P., Capital World Investors, RA CAPITAL MANAGEMENT, L.P., Capital World Investors, Fidelity Management & Research (FMR), among 326 institutional holders.

Which legendary investors own NAMS?

2 of the legendary investors tracked on HoldingsHub report NAMS (NEWAMSTERDAM PHARMA COMPANY) in their latest 13F filings, led by Viking Global Investors, Lee Ainslie. Each is shown at that manager's own most recent quarter.

Do superinvestors agree on NAMS?

2 tracked superinvestors hold NAMS simultaneously — see the consensus page for the stocks they own together.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

Embed this stock on your site

Copy the snippet below to show a live "which legendary investors own NAMS" list on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/stocks/NAMS/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

Preview the embeddable widget →